Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
84 EUR | 0.00% | -1.18% | -12.95% |
06-05 | CARL ZEISS MEDITEC AG : Goldman Sachs reiterates its Sell rating | ZD |
05-31 | Carl Zeiss Meditec just above annual low - JPMorgan skeptical | DP |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
Strengths
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- Historically, the company has been releasing figures that are above expectations.
Weaknesses
- The potential for earnings per share (EPS) growth in the coming years appears limited according to current analyst estimates.
- The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 29.59 times its estimated earnings per share for the ongoing year.
- With an enterprise value anticipated at 3.56 times the sales for the current fiscal year, the company turns out to be overvalued.
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
- The company is highly valued given the cash flows generated by its activity.
- The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
- Over the past twelve months, analysts' consensus has been significantly revised downwards.
- The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.
Ratings chart - Surperformance
Sector: Advanced Medical Equipment & Technology
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-12.95% | 8.07B | - | ||
+7.77% | 218B | B | ||
+10.16% | 189B | B- | ||
+26.21% | 151B | B- | ||
+32.78% | 113B | A- | ||
+1.98% | 64.02B | A- | ||
+14.48% | 52.6B | B+ | ||
+2.92% | 49.85B | B+ | ||
-6.60% | 37.89B | A | ||
-1.07% | 34.92B | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- AFX Stock
- AFXA Stock
- Ratings Carl Zeiss Meditec AG